Amneal Pharmaceuticals

List of Healthcare Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 499.58
5.95 1.21
2.21M
931.03M
US$ 465.120B
US$ 471.02
6.59 1.42
1.45M
237.06M
US$ 111.660B
US$ 69.99
1.11 1.61
7.01M
1.28B
US$ 89.590B
US$ 257.03
3.64 1.44
1.23M
295.87M
US$ 76.050B
US$ 274.26
6.39 2.39
864,539
275.09M
US$ 75.450B
US$ 520.78
5.63 1.09
747,329
124.94M
US$ 65.070B
US$ 66.46
1.52 2.34
3.45M
548.77M
US$ 36.470B
US$ 79.97
0.14 0.18
2.33M
454.68M
US$ 36.360B
US$ 195.00
-3.30 -1.66
1.94M
145.69M
US$ 28.410B
US$ 287.17
4.20 1.48
251,944
58.30M
US$ 16.740B
US$ 21.83
0.30 1.39
311,317
586.83M
US$ 12.810B
US$ 39.00
0.00 0.00
0
244.03M
US$ 9.520B
US$ 98.74
4.03 4.26
776,149
90.70M
US$ 8.960B
US$ 135.46
4.32 3.29
541,732
62.93M
US$ 8.520B
US$ 20.22
0.95 4.93
2.77M
414.83M
US$ 8.390B
US$ 542.70
9.27 1.74
70,554
15.02M
US$ 8.150B
US$ 74.58
2.03 2.80
982,640
101.94M
US$ 7.600B
US$ 16.81
0.38 2.31
1.42M
418.20M
US$ 7.030B
US$ 10.61
0.02 0.19
199,464
636.15M
US$ 6.750B
US$ 69.49
-1.38 -1.95
827,474
92.03M
US$ 6.400B
US$ 62.74
0.44 0.71
469,525
100.24M
US$ 6.290B
US$ 30.49
0.00 0.00
0
179.05M
US$ 5.460B
US$ 54.60
1.40 2.63
923,091
98.12M
US$ 5.360B
US$ 91.61
3.14 3.55
238,942
55.98M
US$ 5.130B
US$ 28.56
0.83 2.99
2.80M
179.76M
US$ 5.130B
US$ 59.26
3.63 6.53
655,994
85.47M
US$ 5.060B
US$ 39.78
1.62 4.25
906,465
126.48M
US$ 5.030B
US$ 24.48
0.65 2.73
3.41M
163.67M
US$ 4.010B
US$ 99.59
3.59 3.74
762,486
39.65M
US$ 3.950B
US$ 33.03
1.48 4.69
1.81M
118.70M
US$ 3.920B
US$ 39.02
1.16 3.06
687,250
94.41M
US$ 3.680B
US$ 28.51
0.86 3.11
260,216
127.13M
US$ 3.620B
US$ 31.03
1.20 4.02
1.10M
112.67M
US$ 3.500B
US$ 21.70
0.39 1.83
901,556
159.83M
US$ 3.470B
US$ 73.98
1.06 1.45
315,090
45.08M
US$ 3.340B
US$ 8.46
0.14 1.68
411,879
376.76M
US$ 3.190B
US$ 25.82
0.76 3.03
661,982
119.08M
US$ 3.070B
US$ 24.84
0.47 1.93
1.80M
115.66M
US$ 2.870B
US$ 79.47
2.79 3.64
277,543
32.58M
US$ 2.590B
US$ 17.20
0.79 4.81
218,113
134.46M
US$ 2.310B
US$ 35.65
0.56 1.60
764,609
62.37M
US$ 2.220B
US$ 32.65
1.77 5.73
634,350
53.36M
US$ 1.740B
US$ 33.74
1.46 4.52
150,513
46.98M
US$ 1.590B
US$ 93.11
2.50 2.76
84,072
16.20M
US$ 1.510B
US$ 106.00
3.02 2.93
105,030
13.06M
US$ 1.380B
US$ 7.37
-0.06 -0.81
4.91M
183.23M
US$ 1.350B
US$ 12.30
0.41 3.45
599,481
109.26M
US$ 1.340B
US$ 10.92
0.52 5.00
890,961
110.22M
US$ 1.200B
CA$ 5.10
-0.01 -0.20
719,936
235.06M
CA$ 1.200B
US$ 6.32
0.42 7.12
806,851
188.38M
US$ 1.190B
US$ 13.99
0.43 3.17
347,818
83.03M
US$ 1.160B
US$ 1.65
0.18 12.24
1.48M
656.47M
US$ 1.080B
US$ 16.19
0.60 3.85
445,016
65.98M
US$ 1.070B
US$ 13.92
0.46 3.42
726,770
74.19M
US$ 1.030B
US$ 7.52
0.79 11.74
19,894
135.63M
US$ 1.020B
US$ 13.07
0.59 4.73
488,999
73.63M
US$ 962.340M
US$ 9.23
0.07 0.76
455,702
103.47M
US$ 955.030M
US$ 62.17
0.85 1.39
59,803
15.32M
US$ 952.440M
US$ 47.47
1.52 3.31
79,634
19.93M
US$ 946.080M
US$ 24.10
0.92 3.97
83,790
30.68M
US$ 739.390M
US$ 49.00
2.11 4.50
118,902
14.17M
US$ 694.330M
US$ 3.59
0.20 5.90
995,092
188.21M
US$ 675.670M
US$ 12.00
0.73 6.48
373,244
56.26M
US$ 675.120M
US$ 3.33
0.15 4.72
928,846
187.94M
US$ 625.840M
US$ 12.23
0.29 2.43
431,038
50.10M
US$ 612.720M
US$ 2.44
0.15 6.55
1.86M
247.92M
US$ 604.920M
US$ 1.68
0.09 5.66
4.29M
357.42M
US$ 600.470M
US$ 4.74
0.62 15.05
1.02M
110.74M
US$ 524.910M
US$ 3.77
0.43 12.87
2.85M
136.75M
US$ 515.550M
US$ 8.20
-0.04 -0.49
141,555
56.78M
US$ 465.600M
US$ 5.39
0.02 0.37
1.04M
83.14M
US$ 448.120M
US$ 1.42
0.04 2.90
2.23M
278.93M
US$ 396.080M
US$ 3.55
0.51 16.78
643,967
111.38M
US$ 395.400M
US$ 12.40
0.40 3.33
82,393
29.74M
US$ 368.780M
US$ 25.27
0.73 2.97
51,409
14.53M
US$ 367.170M
US$ 7.88
0.29 3.82
170,454
45.62M
US$ 359.490M
US$ 0.88
0.04 4.23
4.80M
394.16M
US$ 348.360M
US$ 0.45
0.02 5.75
1.91M
656.56M
US$ 296.900M
US$ 4.43
-0.01 -0.23
17,200
64.33M
US$ 284.980M
US$ 14.60
0.37 2.60
125,802
17.13M
US$ 250.100M
US$ 1.31
0.07 5.65
177,210
185.86M
US$ 243.480M
US$ 12.16
0.21 1.76
208,893
19.95M
US$ 242.590M
CA$ 3.42
0.08 2.40
24,468
65.90M
CA$ 225.380M
US$ 2.20
0.04 1.85
113,073
101.35M
US$ 222.970M
CA$ 8.27
-0.10 -1.19
5,455
25.50M
CA$ 210.760M
US$ 13.85
-0.43 -3.01
107,563
14.68M
US$ 203.320M
US$ 4.16
0.35 9.19
200,249
40.68M
US$ 169.230M
US$ 1.03
-0.01 -0.96
732,394
163.66M
US$ 168.570M
US$ 6.45
-0.55 -7.86
176,050
25.59M
US$ 165.060M
US$ 5.57
0.13 2.39
740,590
26.85M
US$ 149.550M
CA$ 2.27
0.00 0.00
12,400
57.67M
CA$ 130.910M
CA$ 2.74
0.04 1.48
6,525
43.62M
CA$ 119.520M
US$ 5.69
0.30 5.57
51,489
20.10M
US$ 114.370M
US$ 2.38
0.12 5.31
22,202
46.89M
US$ 111.600M
US$ 1.17
-0.01 -0.85
12,107
78.16M
US$ 91.450M
US$ 0.60
-0.11 -16.06
1.94M
151.62M
US$ 90.970M
US$ 1.52
0.02 1.33
26,089
58.61M
US$ 89.090M
US$ 2.56
0.08 3.23
8,687
32.58M
US$ 83.400M
CA$ 0.23
0.03 15.00
343,433
265.18M
CA$ 60.990M
US$ 8.44
0.00 0.00
4,900
7.08M
US$ 59.760M
US$ 1.36
0.00 0.00
480
43.42M
US$ 59.050M
US$ 0.29
0.09 46.50
102.03M
176.84M
US$ 51.810M
US$ 2.94
0.09 3.16
30,206
15.59M
US$ 45.830M
US$ 1.32
0.00 0.00
0
33.47M
US$ 44.180M
US$ 0.43
-0.0099 -2.25
49,579
102.30M
US$ 44.000M
US$ 0.58
0.0088 1.54
34,128
73.84M
US$ 42.830M
US$ 0.93
0.007 0.76
341
43.53M
US$ 40.350M
US$ 4.72
-0.15 -3.08
512
8.30M
US$ 39.180M
US$ 0.38
0.00 0.00
0
102.22M
US$ 38.950M
US$ 0.17
0.0036 2.22
658,189
208.50M
US$ 34.590M
US$ 1.30
0.05 4.00
94,046
25.45M
US$ 33.080M
US$ 0.43
0.03 7.20
183,670
75.35M
US$ 32.760M
US$ 1.45
0.04 2.84
124,938
22.37M
US$ 32.440M
US$ 0.26
0.03 12.26
343,635
116.76M
US$ 30.360M
US$ 4.71
-0.16 -3.29
343,502
6.09M
US$ 28.680M
CA$ 0.37
0.02 4.29
9,934
77.70M
CA$ 28.360M
US$ 0.69
-0.0012 -0.17
29,717
40.80M
US$ 27.950M
US$ 1.53
-0.07 -4.38
81,374
16.78M
US$ 25.670M
0.29
-0.01 -3.33
188,600
85.05M
24.660M
CA$ 0.45
-0.01 -2.17
3,600
50.91M
CA$ 22.910M
US$ 1.04
0.03 2.71
468
20.53M
US$ 21.300M
0.40
0.00 0.00
0
50.38M
19.900M
US$ 1.20
0.10 9.09
138,264
16.02M
US$ 19.220M
US$ 0.66
0.0052 0.79
151,491
29.01M
US$ 19.140M
US$ 0.13
-0.0026 -1.98
2.66M
144.26M
US$ 18.570M
US$ 2.31
0.00 0.00
0
7.70M
US$ 17.790M
US$ 2.86
-0.06 -2.05
20,294
6.21M
US$ 17.760M
US$ 0.60
0.0093 1.58
325,377
25.61M
US$ 15.340M
US$ 1.80
-0.18 -9.09
673
8.47M
US$ 15.250M
CA$ 0.26
-0.01 -3.70
19,000
55.42M
CA$ 14.410M
US$ 3.16
0.17 5.69
23,601
4.28M
US$ 13.520M
US$ 0.46
0.0067 1.49
63,346
29.32M
US$ 13.400M
CA$ 0.16
0.03 19.23
163,500
86.21M
CA$ 13.360M
CA$ 0.08
0.005 7.14
460,000
148.92M
CA$ 11.170M
CA$ 0.13
-0.01 -7.14
6,500
84.33M
CA$ 10.960M
US$ 0.33
0.0015 0.46
143,655
27.17M
US$ 8.990M
CA$ 0.10
0.00 0.00
53,500
90.68M
CA$ 8.610M
CA$ 0.15
0.01 7.14
6,000
56.21M
CA$ 8.430M
US$ 1.02
-0.01 -0.97
272,638
7.86M
US$ 8.020M
US$ 0.98
0.02 2.34
1,209
7.03M
US$ 6.910M
CA$ 0.12
0.00 0.00
0
57.61M
CA$ 6.910M
CA$ 0.06
0.02 37.50
1.12M
124.02M
CA$ 6.820M
CA$ 0.28
0.005 1.82
5,000
23.61M
CA$ 6.610M
US$ 3.01
-0.009 -0.30
7,831
1.88M
US$ 5.650M
0.12
0.01 9.09
10,001
44.21M
5.310M
US$ 0.96
-0.02 -1.74
119,292
5.35M
US$ 5.150M
0.05
-0.005 -9.09
129,384
99.33M
4.970M
CA$ 0.05
0.005 11.11
57,000
93.72M
CA$ 4.690M
CA$ 0.10
0.00 0.00
4,000
45.90M
CA$ 4.590M
US$ 0.03
0.00 0.00
0
140.03M
US$ 4.090M
US$ 0.26
-0.0002 -0.08
167,950
13.02M
US$ 3.320M
0.005
0.00 0.00
48,778
365.36M
1.830M
CA$ 0.56
-0.09 -13.85
18,320
1.53M
CA$ 857K
CA$ 0.02
0.00 0.00
0
39.82M
CA$ 796K
CA$ 0.02
0.00 0.00
0
41.14M
CA$ 617K
US$ 0.02
-0.0057 -21.92
11,888
19.89M
US$ 404K
CA$ 0.70
0.00 0.00
6,000
-
CA$ -
US$ 12.71
-0.04 -0.31
2,187
-
US$ -

Latest Healthcare Stock News


Acadia Healthcare Appoints Heather Dixon as Chief Financial Officer

Dixon Brings Over 25 Years of Financial and Healthcare Experience David Duckworth to Step Down After 12 Years as Acadia’s CFO Larry Harrod, EVP, Finance Announces Retirement; Tim Sides to Assume Responsibilities Company Reaffirms Full Year Fiscal 2023 Guidance FRANKLIN, Tenn. / Jun 01, 2023 / Business Wire / Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia” or the “Company”) today announced Heather Dixon has been appointed Chief Financial Officer... Read more


EmpiRx Health Names Healthcare and Technology Veteran Danny Sanchez as CEO

Sanchez, Who Joined EmpiRx Health Earlier this Year as President, Assumes CEO Role – Reinforces Commitment to Company's Healthcare Mission MONTVALE, N.J., June 1, 2023 /PRNewswire/ -- EmpiRx Health, the industry's only value-based PBM, today announced that the company's president, Danny Sanchez, has been named Chief Executive Officer. As part of a planned transition, Sanchez succeeds Karthik Ganesh who has served as President and then CEO of EmpiRx Health during the... Read more


CarepathRx Health System Solutions and Evernorth Health Services Forge Strategic Partnership to Enhance Specialty Care for Patients

BLOOMFIELD, Conn. and MERCER ISLAND, Wash., June 1, 2023 /PRNewswire/ -- CarepathRx Health System Solutions (CHSS), a CarepathRx company and portfolio company of Nautic Partners (Nautic), and Evernorth Health Services, a subsidiary of The Cigna Group (NYSE: CI), announced a new strategic partnership and investment by Evernorth in CHSS. The strategic partnership brings together Evernorth's diverse specialty and care expertise with CHSS' robust pharmacy and infusion management... Read more


Accolade To Present at Stifel 2023 Cross Sector Insight Conference

SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stifel 2023 Cross Sector Insight Conference in Boston on Tuesday, June 6, 2023 at 11:30 am ET. A webcast of the event will be available at ir.accolade.com and a replay will be available for 90 days. About Accolade, Inc. Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that... Read more


Chemed to Present at the Jefferies 2023 Healthcare Conference

CINCINNATI / Jun 01, 2023 / Business Wire / Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2023 Healthcare Conference on Thursday, June 8, 2023, at approximately 11:30 a.m. (ET) at the New York Marriott Marquis in New York City. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available... Read more


Netramark Announces Private Placement Financing

TORONTO, June 1, 2023 /CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (Frankfurt: 8TV) (OTC: AINMF) is pleased to announce a non-brokered private placement financing (the "Offering") of up to 1,351,351 units of the Company (the "Units") at a price of $0.37 per Unit, for aggregate gross proceeds of up to $500,000 (the "Offering"). Each Unit will consist of one common share in the capital of the Company (each, a "Unit Share") and one common share... Read more


Jack Nathan Health Announces Its Q4 and Year End Fiscal 2023 Financial Results

Fiscal 2023 Revenue of $15.5m Increased 61% over Fiscal 2022 TORONTO / Jun 01, 2023 / Business Wire / Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2023, and fiscal year ended January 31, 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting... Read more


Veeva Systems Announces Fiscal 2024 First Quarter Results

Total Revenues of $526.3M, up 4% Year Over Year; Subscription Services Revenues of $414.5M, up 3% Year Over Year PLEASANTON, Calif., May 31, 2023 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2023. "It was a strong start to the year for Veeva and we are executing well on our goal to power the most critical functions... Read more


Definitive Healthcare to Present at the Stifel 2023 Cross Sector Insight Conference and the 43rd Annual William Blair Growth Stock Conference

FRAMINGHAM, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will present at two upcoming conferences: the Stifel 2023 Cross Sector Insight Conference in Boston, MA and the 43rd Annual William Blair Growth Stock Conference in Chicago, IL. Founder and Executive Chairman, Jason Krantz, will present at the Stifel Conference on... Read more


Phreesia Announces First Quarter Fiscal 2024 Results

WILMINGTON, Del. / May 31, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2023. "Our team got off to a solid start in fiscal 2024. Across the organization, we made meaningful progress toward achieving our goals of continued growth and a return to profitability, while maintaining our ongoing commitment to optimal patient outcomes," said CEO and Co-Founder Chaim... Read more


Universal Health Services To Present At The 44th Annual Goldman Sachs Global Healthcare Conference

KING OF PRUSSIA, Pa., May 31, 2023 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will participate in a fireside chat at the 44th Annual Goldman Sachs Global Healthcare Conference on Monday, June 12, 2023, at 4:40pm (PT)/7:40pm (ET). A live audio webcast of the presentation will be available on the Company's website (www.uhs.com).  For those unable to listen to the... Read more


U.S. Physical Therapy Announces Acquisition of a Four-Clinic Physical Therapy Practice

HOUSTON / May 31, 2023 / Business Wire / U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced an acquisition of a physical therapy practice with four clinics. USPH and its local partners together acquired a 75% equity interest in the practice for a purchase price of $3.1 million, with the current practice owners retaining a... Read more


Center for Primary Care (CPC) Forms Long-term Partnership with agilon health, Bringing Value-Based Primary Care to the Central Savannah River Area (CSRA)

CPC and agilon are committed to accelerating access to value-based care to improve health outcomes for senior patients For the first time, agilon’s Total Care Model expands to Eastern Georgia within the CSRA EVANS, Ga. & AUSTIN, Texas / May 31, 2023 / Business Wire / The Center for Primary Care (CPC), an independent practice dedicated to providing comprehensive preventative and specialized care, announced today it has formed a new partnership with agilon health... Read more


Cognetivity Neurosciences Announces Collaboration with Alzheimer's Society to Further Expand its AI Algorithms

Agreement aims at further development of Cognetivity's AI (Artificial Intelligence) platform through investigating comorbidities in diabetes and dementia Vancouver, British Columbia--(Newsfile Corp. - May 31, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity"), a leading provider of brain health solutions powered by AI, is excited to announce a collaboration with the Alzheimer's Society in Oman. This... Read more


Tenet Healthcare to Participate in 44th Annual Goldman Sachs Global Healthcare Conference

DALLAS / May 31, 2023 / Business Wire / Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the 44th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 13, 2023, beginning at 9:20 a.m. Pacific time (12:20 p.m. Eastern Time). A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet’s website at https://investor.tenethealth.com/. The replay will be available for 30 days. About Tenet He... Read more


SOPHiA GENETICS Announces Nomination of Lila Tretikov to Board of Directors

Microsoft's Deputy Chief Technology Officer to be appointed at Annual Shareholders' Meeting BOSTON and LAUSANNE, Switzerland, May 31, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the nomination of Lila Tretikov to its Board of Directors. The Board of Directors has proposed the appointment of Tretikov as a member of the board at the Annual General... Read more


Cano Health Appoints Frederick Green as Interim Chief Legal Officer

MIAMI, May 31, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced the appointment of Frederick S. Green as its Interim Chief Legal Officer, effective immediately. In this role, Mr. Green will work closely with the Company's Board and management team to implement and maintain best-in-class corporate governance practices, support execution of the Company's stockholder... Read more


Hydreight Technologies Announces Q1 Financial Highlights

VANCOUVER, British Columbia and LAS VEGAS, May 31, 2023 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (FSE: SO6)(OTCQB: HYDTF) an on-demand home healthcare and wellness platform, is pleased to announce that the Company’s total top-line non-GAAP Adjusted Revenue* for Q1 2023 reached C$4,167,670 representing a growth rate of 211% over the Company’s Q1 2022 Adjusted Revenue* of C$1,339,818. “We are proud to report that we... Read more


GE HealthCare Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI

A type of artificial intelligence (AI), Deep Learning (DL) technology can advance medical imaging capabilities by providing more robust, accurate, and data-driven information as well as support more efficient workflows and exams Precision DL for PET/CT is the latest addition to GE HealthCare’s Effortless Recon DL portfolio of deep learning-based solutions – which also includes AIR Recon DL for MRI, TrueFidelity for CT, and Helix DL for X-ray – to significantly improve... Read more


Numinus Wellness to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study

The research conducted at Cedar Clinical Research in Draper is part of the first ever phase 3 program of psilocybin therapy, and the largest of its kind VANCOUVER, BC, May 30, 2023 /CNW/ - Numinus Wellness Inc. (TSX: NUMI) is pleased to announce that Cedar Clinical Research (CCR) has begun studying COMP360 psilocybin therapy, an investigational new therapy for treatment-resistant depression (TRD), as part of the largest-ever international clinical study of psilocybin... Read more


Lotus Clinical Research Expands Partnership with Veeva Systems to Accelerate Clinical Trials

Fast-growing CRO utilizes Veeva Vault Clinical Suite to substantially decrease startup time NEW PROVIDENCE, N.J. and PLEASANTON, Calif., May 30, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Lotus Clinical Research expanded its partnership with Veeva and broadened its adoption of Veeva Vault Clinical Suite, a strategic move to strengthen its service delivery and efficiency. This builds on Lotus' existing use of Vault Clinical Suite to implement... Read more


Marpai Launches Marpai Connect Platform to Predict and Help Modify Risk in Healthcare

Marpai Connect proactively matches members to best-in-class value-based providers to improve member health and lower costs for employers NEW YORK, May 30, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an artificial intelligence (AI)-powered healthcare payer transforming self-funded employer health plans, is proud to announce the launch of its innovative platform, Marpai Connect. Marpai Connect, an AI and data-driven matchmaking platform,... Read more


Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

The London Clinic is the UK’s most renowned independent, private hospital, established 1932. The London Spine Clinic is first specialist spinal unit established in England, 1997. The London Clinic will be Aclarion’s first customer in London. BROOMFIELD, CO, May 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers... Read more


PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform

VANCOUVER, BC, May 30, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023 ("LOI") with Interactive Health Inc. ("IHI"), whereby PanGenomic Health will license IHI's CyberPatient AI medical education platform ("CyberPatient AI Platform") for the exclusive use in the consumer, public health, and complementary and alternative medicine... Read more


Biote Appoints Mary J. Puncochar as Chief Commercial Officer

Ms. Puncochar to Drive Execution of Biote’s Strategic Sales and Marketing Initiatives IRVING, Texas / May 30, 2023 / Business Wire / biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced the appointment of Mary J. Puncochar as Chief Commercial Officer. In this role, Ms. Puncochar will lead Biote’s commercial initiatives to expand the... Read more


Tenet Healthcare Announces Appointment of Stephen H. Rusckowski to Board of Directors

DALLAS / May 30, 2023 / Business Wire / Tenet Healthcare Corporation (NYSE: THC) today announced the appointment of Stephen H. Rusckowski to the Tenet Board of Directors, effective immediately. Rusckowski will serve as a member of the human resources committee and quality, compliance, and ethics committee. This appointment expands the Board to 11 directors, 10 of whom are independent members. “We are pleased to announce Steve Rusckowski as a new board member for Tenet,”... Read more


Omnicell Announces Leadership and Organizational Changes

FORT WORTH, Texas / May 30, 2023 / Business Wire / Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced changes to its leadership structure designed to create a more streamlined organization with a continued focus on operational excellence, driving continuous improvements in customer experience and the delivery of Omnicell’s long-term commitments. “Omnicell continues to evolve... Read more


Premier Health Reports Second Quarter Results

MONTREAL, May 29, 2023 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces it has filed its Unaudited Quarterly Consolidated Financial Statements and MD&A for its first quarter ended March 31, 2023. First Quarter 2023 Highlights (in Canadian dollars) March 31, 2023(3 months) March 31, 2022(3 months) March 31, 2023(6 months) March 31, 2022(6 months) Revenues 21... Read more


Schrödinger to Present at Jefferies Global Biopharma Conference

NEW YORK / May 26, 2023 / Business Wire / Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference. The live presentation will take place on Wednesday, June 7, 2023, at 2:30 p.m. ET. The live discussion can be accessed under "News & Events" in the investors section of Schrödinger’s... Read more


COMPASS Pathways: Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023

More than half of the patients demonstrated remission of depression at 18 months, after a single dose of 25mg investigational COMP360 psilocybin with psychological support Open label phase 2 study, conducted by Sunstone Therapies and scheduled to be presented at the ASCO annual meeting on June 5, is believed to be the longest clinical study of psilocybin ever conducted LONDON, May 26, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a... Read more


Mednow to Present at the Gravitas’ 4th Los Angeles Summit

TORONTO / May 26, 2023 / Business Wire / Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF) – Mednow is pleased to announce it will be presenting at Gravitas’ 4th Los Angeles Summit, which will be taking place at The Beverly Hills Hotel from Sunday, June 4th to Tuesday, June 6th, 2023, in Beverly Hills, California. Ali Reyhany, CEO, is scheduled to present on Tuesday, June 6th, 2023, at 10 am PDT. Ali will also be fielding investor questions during the in-person summit. Gravitas’... Read more


Novo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial Results

BELLEVUE, Wash. / May 26, 2023 / Business Wire / Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the fiscal quarter ended February 28, 2023. Robert Mattacchione, Novo’s CEO and Board Chairman, stated,... Read more


St. Luke’s University Health Network Selects GE HealthCare for $30 Million Purchase of Cutting-Edge CT Technology, Powered by Artificial Intelligence

St Luke’s $30 million investment in 21 GE HealthCare CT systems makes it one of the health system’s largest investments of its kind Continuous Artificial Intelligence (AI) and software updates will be provided by GE HealthCare’s Smart Subscription, a service to help extend the life of the CT Fleet CHICAGO / May 25, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leading medical technology innovator, announced today its largest ever CT deal in the United... Read more


Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes

LONDON and CHICAGO, May 25, 2023 (GLOBE NEWSWIRE) -- Renalytix (NASDAQ: RNLX) (LSE: RENX), the first company to develop and commercialize an artificial intelligence (AI) powered in-vitro diagnostic for kidney disease, has selected EVERSANA, a global leader in life-science commercialization services, to expand the company’s commercial footprint for KidneyIntelX, a prognostic device for patients with diabetic kidney disease. Using highly reliable, bioprognostic™ methodology,... Read more


Numinus Wellness Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted Therapy

First Numinus Network™ partner enters into agreement Recent cost containment initiatives have resulted in approximately $4.2 million of annualized savings, extending cash runway Well positioned to provide psychedelic-assisted therapy insurance reimbursement, as a result of recent US insurance payor code approval MDMA-assisted therapy expected to be approved for treatment in US in 2024 – Numinus well positioned to be a key provider of this therapy VANCOUVER,... Read more


Ontrak Achieves NCQA Certification as a Credentials Verification Organization, Reinforcing Commitment to Quality Assurance in Healthcare

HENDERSON, Nev. / May 25, 2023 / Business Wire / Ontrak, Inc. (NASDAQ: OTRK), a leading AI-powered and telehealth-enabled health care company, is proud to announce its recent certification by the National Committee for Quality Assurance (NCQA) as a Credentials Verification Organization (CVO) for the element of license to practice. This certification further validates Ontrak's commitment to maintaining the highest standards of quality and compliance in its suite of health... Read more


Mangoceuticals Adds Renowned Tech Entrepreneur and Investor, Aaron Andrew, to Advisory Board

Dallas, Texas, May 25, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” is pleased to announce that it has added serial technology entrepreneur and investor, Aaron Andrew, to its advisory board (the... Read more


Neupath Health Delivers Strong Quarterly Revenues And Improves Cash Position

Delivered first quarter revenue of $16.1 million, up 4.2% year over year Adjusted EBITDA(1) of $0.7 million, our 17th consecutive quarter of positive adjusted EBITDA Continued focus on operational improvements and new services to better serve our patients TORONTO / May 25, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today... Read more


10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay

Combining tissue profiling with whole transcriptome spatial analysis and high-plex protein co-detection enables a deeper, more holistic understanding of tissue organization PLEASANTON, Calif., May 24, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of a new Visium CytAssist Gene and Protein Expression product to expand the breadth of the Visium CytAssist spatial analysis ca... Read more


LifeStance Health Group to Present at the 44th Annual Goldman Sachs Healthcare Conference

SCOTTSDALE, Ariz., May 24, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 44th Annual Goldman Sachs Healthcare Conference, which will be hosted in Dana Point, CA. Details of the presentation are as follows:Presenter: Dave Bourdon, CFODate: Wednesday, June 14, 2023 Time: 11:20 a.m. (Pacific time)Moderated by: Jamie... Read more


GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

NCCN Guidelines® for clinicians and patients now recommend the use of FES PET for ER+ positive disease under certain circumstances during the systemic staging workup of patients with recurrent or metastatic breast cancer (MBC). Cerianna (fluoroestradiol F18) injection is the first and only U.S. Food and Drug Administration (FDA) approved imaging agent helping clinicians assess estrogen receptor-positive (ER+) lesion status to potentially aid in better informing clinical... Read more


Minaris Regenerative Medicine Streamlining Contract Manufacturing with Veeva Systems Vault Quality Suite Applications

Global CDMO unifies quality content and training for greater visibility and agility PLEASANTON, Calif., May 24, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Minaris Regenerative Medicine, a leading contract development and manufacturing organization (CDMO) focused on cell and gene therapies, selected Veeva Vault QualityDocs and Veeva Vault Training to advance its global quality operations. Minaris Regenerative Medicine will use Veeva's unified... Read more


Institute of Oncology Ljubljana Leverages SOPHiA GENETICS DDM™ Platform for Cancer Research

SOPHiA DDM™ deep-learning algorithm will help determine HRD status of tumors for Institute of Oncology Ljubljana researchers BOSTON and LAUSANNE, Switzerland, May 24, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that the Institute of Oncology Ljubljana (IOL), a comprehensive public institution for detection, treatment and research of... Read more


Reformulary Group and Mednow Partner to Advance the Mission of Making Medications More Transparent, More Accessible, and More Affordable for All Canadians

By blending technological innovations, this groundbreaking partnership offers mutual patients more choice, better value, and easy access to expert advice related to drugs that provide the best healthcare value in a digital age. It also intends to extend affordable access to prescription drugs to groups such as gig workers- traditionally left out of most healthcare plans. TORONTO / May 24, 2023 / Business Wire / Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF) is proud to announce... Read more


Alignment Healthcare to Participate in the William Blair 43rd Annual Growth Stock Conference and Goldman Sachs 44th Annual Global Healthcare Conference

ORANGE, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will participate in the following conferences: William Blair 43rd Annual Growth Stock Conference, including a presentation on Wednesday, June 7, at 11:20 a.m. CDT Goldman Sachs 44th Annual Global Healthcare Conference, including a presentation... Read more


GE HealthCare to Present at Jefferies Healthcare Conference

NEW YORK / May 24, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, is announcing today that its President and CEO Peter Arduini will present at the Jefferies Healthcare Conference in New York City on June 7, 2023 from 10:30 am to 10:55 am ET. This event can be accessed live by visiting GE HealthCare’s Investor Relations website at: https://wsw.com/webcast/jeff281/gehc/1817530. About GE HealthCare Technologies Inc. GE HealthCare... Read more


Centene Announces New Chief Communications Officer

ST. LOUIS, May 24, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it has named Shannon T. Susko as its Senior Vice President and Chief Communications Officer. Ms. Susko will be responsible for Centene's communications function, leading the development and execution of all internal and external communications, overseeing corporate reputation and advancing communications... Read more


Victory Square Portfolio Company Hydreight Technologies Achieves Record-Breaking CAD$1.4 Million Monthly Top Line Adjusted Revenue**

“Hydreight recently announced record revenue for fiscal year 2022, and they’ve kept up the momentum in 2023. Victory Square owns 73.72% of Hydreight, so its success will have a huge impact on Victory Square and our shareholders.” Said Shafin Diamond Tejani, CEO of Victory Square Technologies. VANCOUVER, British Columbia, May 24, 2023 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that... Read more


Novo Integrated Sciences Reports Fiscal Year 2023 First Quarter Financial Results

BELLEVUE, Wash. / May 24, 2023 / Business Wire / Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the fiscal quarter ended November 30, 2022. Robert Mattacchione, Novo’s CEO and Board Chairman, stated,... Read more


Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™

Company to Deliver to Patients FDA-Approved Topical Treatment for Dystrophic Epidermolysis Bullosa (DEB) Announces Collaboration with Amedisys to Administer Treatment in the Home BANNOCKBURN, Ill., May 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH) today announced that it was selected by Krystal Biotech, Inc. (“Krystal Biotech”) (Nasdaq: KRYS) as part of a limited distribution specialty pharmacy network for VYJUVEK™.... Read more

COPYRIGHT ©2023 HEALTH STOCKS HUB